Fuzzy logic-based tumor marker profiles including a new marker Tumor M2-PK improved sensitivity to the detection of progression in lung cancer patientsSCHNEIDER, Joachim; PELTRI, Gregor; BITTERLICH, Norman et al.Anticancer research. 2003, Vol 23, Num 2A, pp 899-906, issn 0250-7005, 8 p.Conference Paper

Expression of tumor markers on breast and ovarian cancer cell linesKÄMMERER, Ulrike; THANNER, Florian; KAPP, Michaela et al.Anticancer research. 2003, Vol 23, Num 2A, pp 1051-1055, issn 0250-7005, 5 p.Conference Paper

Criteria for the selection of referential groups in tumor marker statistical evaluation on the basis of a retrospective studyHOLUBEC, L. JR; TOPOLCAN, O; PIKNER, R et al.Anticancer research. 2003, Vol 23, Num 2A, pp 865-870, issn 0250-7005, 6 p.Conference Paper

Differential expression of IGFBP-5 and two human ESTs in thyroid glands with goiter, adenoma and papillary or follicular carcinomasSTOLF, Beatriz S; CARVALHO, Alex F; REIS, Luiz F. L et al.Cancer letters. 2003, Vol 191, Num 2, pp 193-202, issn 0304-3835, 10 p.Article

Atypical courses of serum tumor markers: 4 Case reportsKLAPDOR, R; BAHLO, M; BABINSKI, A et al.Anticancer research. 2003, Vol 23, Num 2A, pp 845-850, issn 0250-7005, 6 p.Conference Paper

An intelligent decision support algorithm for diagnosis of colorectal cancer through serum tumor markersJINGHUA SHI; QIANG SU; CHENPENG ZHANG et al.Computer methods and programs in biomedicine (Print). 2010, Vol 100, Num 2, pp 97-107, issn 0169-2607, 11 p.Article

Prospective evaluation of CEA and CA 15.3 in patients with locoregional breast cancerMOLINA, R; FILELLA, X; ALICARTE, J et al.Anticancer research. 2003, Vol 23, Num 2A, pp 1035-1041, issn 0250-7005, 7 p.Conference Paper

Joint detection of tumor markers with imaging ellipsometry biosensorYU NIU; TENGFEI KANG; GANG JIN et al.Thin solid films. 2014, Vol 571, pp 453-462, issn 0040-6090, 10 p., 3Conference Paper

Prospective evaluation of tumor markers (c-erbB-2 oncoprotein, CEA and CA 15.3) in patients with locoregional breast cancerMOLINA, R; FILELLA, X; ZANON, G et al.Anticancer research. 2003, Vol 23, Num 2A, pp 1043-1050, issn 0250-7005, 8 p.Conference Paper

Changes in the expression of serum markers CA242, CA199, CA125, CEA, TNF-α and TSGF after cryosurgery in pancreatic cancer patientsGANG ZHOU; LIZHI NIU; CHIU, David et al.Biotechnology letters. 2012, Vol 34, Num 7, pp 1235-1241, issn 0141-5492, 7 p.Article

REporting recommendations for tumor MARKer prognostic studies (REMARK)MCSHANE, Lisa M; ALTMAN, Douglas G; SAUERBREI, Willi et al.Breast cancer research and treatment. 2006, Vol 100, Num 2, pp 229-235, issn 0167-6806, 7 p.Article

Increased prolyl endopeptidase activity in human neoplasiaLARRINAGA, Gorka; PEREZ, Itxaro; BLANCO, Lorena et al.Regulatory peptides. 2010, Vol 163, Num 1-3, pp 102-106, issn 0167-0115, 5 p.Article

Electrochemiluminescence immunosensor for tumor markers based on biological barcode mode with conductive nanospheresSHUPING DU; ZHIYONG GUO; BEIBEI CHEN et al.Biosensors & bioelectronics. 2014, Vol 53, pp 135-141, issn 0956-5663, 7 p.Article

Colorimetric multiplexed immunoassay for sequential detection of tumor markersJING WANG; YA CAO; YUANYUAN XU et al.Biosensors & bioelectronics. 2009, Vol 25, Num 2, pp 532-536, issn 0956-5663, 5 p.Article

Differential PIAS3 expression in human malignancyLIMING WANG; BANERJEE, Sipra.Oncology reports. 2004, Vol 11, Num 6, pp 1319-1324, issn 1021-335X, 6 p.Article

Serum Levels of CA15-3, KL-6 and BCA225 Are Positively Correlated with Each Other in the General PopulationRI, Gyokuto; OHNO, Satoshi; YAMAMOTO, Toshiyuki et al.Anticancer research. 2009, Vol 29, Num 10, pp 4239-4242, issn 0250-7005, 4 p.Article

Tumormarker―Möglichkeiten und Grenzen = Marqueurs tumoraux. Possibilités et limites = Tumor markers-possibilities and limitsROSE, H; SAUL, G; WOLF, G et al.Radiobiologia, radiotherapia. 1984, Vol 25, Num 1, pp 7-19, issn 0033-8184Article

Serum MUC5AC mucin as a potential marker for cholangiocarcinomaWONGKHAM, Sopit; SHEEHAN, John Kieran; BOONLA, Chanchai et al.Cancer letters. 2003, Vol 195, Num 1, pp 93-99, issn 0304-3835, 7 p.Article

Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, β-chorionic gonadotrophin, and prostate-specific antigen = Evaluation immunocytochimique des cancers de la prostate chez l'homme pour l'antigène carcinoembryonnaire, l'antigène à réaction croisée non spécifique, la gonadotrophine bêta-chorionique et l'antigène spécifique de la prostatePURNELL, D. M; HEATFIELD, B. M; TRUMP, B. F et al.Cancer research (Baltimore). 1984, Vol 44, Num 1, pp 285-292, issn 0008-5472Article

Principaux marqueurs biologiques du cancer = The main biological markers in neoplasmsBOHUON, C; BELLET, D.Concours médical (Paris). 1983, Num 39, pp 7-35, issn 0010-5309Article

Trypsinogen activation peptide (TAP) expression in gallbladder bile identifies bilio-pancreatic carcinomaBROCKMANN, Jens G; HERNANDEZ, Carlos A; EMPARAN, Carlos et al.Anticancer research. 2003, Vol 23, Num 2A, pp 819-825, issn 0250-7005, 7 p.Conference Paper

Immunologische und Biochemische Diagnostik maligner Tumoren = Diagnostic immunologique et biochimique des tumeurs malignes = Immunological and biochemical diagnosis of malignant tumorsOHLENSCHLÄGER, G; BERGER, I.Labor - Medizin (GIT-Verlag Giebeler). 1984, Vol 7, Num 1, pp 36-41, issn 0170-205XArticle

Detection of breast cancer cells specially and accurately by an electrochemical methodTING LI; QI FAN; TAO LIU et al.Biosensors & bioelectronics. 2010, Vol 25, Num 12, pp 2686-2689, issn 0956-5663, 4 p.Article

A channel-resolved approach coupled with magnet-captured technique for multianalyte chemiluminescent immunoassayZHIFENG FU; FENG YAN; HONG LIU et al.Biosensors & bioelectronics. 2008, Vol 23, Num 10, pp 1422-1428, issn 0956-5663, 7 p.Article

Use of multidimensional data analysis for prediction of lung malignityMRAZOVA, Viera; MOCAK, Jan; VARMUSOVA, Elena et al.Journal of pharmaceutical and biomedical analysis. 2009, Vol 50, Num 2, pp 210-215, issn 0731-7085, 6 p.Article